HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stimulation of carnitine palmitoyltransferase 1 improves renal function and attenuates tissue damage after ischemia/reperfusion.

AbstractBACKGROUND:
Renal injury as a result of ischemia/reperfusion (I/R) is a major clinical problem with a high mortality rate and a lack of therapeutic treatment. During I/R, cellular homeostasis is disrupted owing to energy depletion, leading to cell death. Fatty acid β-oxidation is the major metabolic pathway for generating adenosine triphosphate (ATP) in the kidneys, which is governed by carnitine palmitoyltransferase 1 (CPT1). C75 is a synthetic compound that up-regulates CPT1 activity. Thus, we hypothesized that C75 treatment could increase energy production and alleviate renal I/R injury.
METHODS:
We subjected male adult rats to renal I/R by bilateral renal pedicle clamping with microvascular clips for 60 min, followed by administration of 8% dimethyl sulfoxide (vehicle) or C75 (3 mg/kg body weight), with 5 animals/group. We collected blood and renal tissues 24 h after reperfusion and subjected them to various measurements and histological examination.
RESULTS:
C75 treatment restored the loss of CPT1 activity and intracellular ATP levels in the kidneys after I/R. Administration of C75 significantly lowered serum creatinine, blood urea nitrogen, aspartate aminotransferase, and lactate dehydrogenase levels elevated by I/R. C75 treatment preserved morphological features of the kidneys with a significant improvement in the damage score. In addition, C75 treatment inhibited the increase of TNF-α levels in serum and kidneys, and lowered myeloperoxidase activity in the kidneys after I/R.
CONCLUSIONS:
Stimulation of CPT1 activity by C75 recovered ATP depletion, improved renal function, attenuated tissue injury, and inhibited proinflammatory cytokine production and neutrophil infiltration after renal I/R injury. Therefore, enhancing the metabolism pathways for energy production may provide a novel modality to treat renal I/R injury.
AuthorsJuan-Pablo Idrovo, Weng-Lang Yang, Jeffrey Nicastro, Gene F Coppa, Ping Wang
JournalThe Journal of surgical research (J Surg Res) Vol. 177 Issue 1 Pg. 157-64 (Sep 2012) ISSN: 1095-8673 [Electronic] United States
PMID22698429 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Tumor Necrosis Factor-alpha
  • Adenosine Triphosphate
  • Peroxidase
  • Carnitine O-Palmitoyltransferase
  • 4-Butyrolactone
Topics
  • 4-Butyrolactone (analogs & derivatives, pharmacology, therapeutic use)
  • Acute Kidney Injury (immunology, prevention & control)
  • Adenosine Triphosphate (biosynthesis)
  • Animals
  • Carnitine O-Palmitoyltransferase (metabolism)
  • Edema (prevention & control)
  • Energy Metabolism
  • Kidney (drug effects, metabolism)
  • Leukocytes (physiology)
  • Male
  • Peroxidase (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (immunology, prevention & control)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: